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This review is based in part on a roundtable discussion session: ‘‘Physiological roles for heterotypic/
heteromeric channels’’ at the 2013 International Gap Junction Conference (IGJC 2013) in Charleston,
South Carolina. It is well recognized that multiple connexins can speciﬁcally co-assemble to form
mixed gap junction channels with unique properties as a means to regulate intercellular communi-
cation. Compatibility determinants for both heteromeric and heterotypic gap junction channel
formation have been identiﬁed and associated with speciﬁc connexin amino acid motifs.
Hetero-oligomerization is also a regulated process; differences in connexin quality control and
monomer stability are likely to play integral roles to control interactions between compatible
connexins. Gap junctions in oligodendrocyte:astrocyte communication and in the cardiovascular
system have emerged as key systems where heterotypic and heteromeric channels have unique
physiologic roles. There are several methodologies to study heteromeric and heterotypic channels
that are best applied to either heterologous expression systems, native tissues or both. There
remains a need to use and develop different experimental approaches in order to understand the
prevalence and roles for mixed gap junction channels in human physiology.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Proteins known as connexins form gap junction channels that
provide a direct connection enabling the exchange of small mole-
cules between adjacent cells. Different connexins form channels
with different permeability and gating characteristics that dictate
the type of intercellular communication they mediate. Moreover,
different connexins are subject to different classes of posttransla-
tional modiﬁcation, such as phosphorylation, which further regu-
late gap junctional communication.
As an added level of complexity, gap junction channels can be
formed containing more than one connexin isoform [1,2]. This al-
lows formation of channels with unique gating and permeability
that would not be otherwise attainable with channels composed
of a single connexin isoform. Not all connexins are compatible tointeract, which enables speciﬁc networks of interconnected cells
to be formed and independently regulated.
There are now considerable data demonstrating which connex-
ins are compatible to form a mixed gap junction channels and
which cannot. Most of the evidence in support of the potential
for connexins to interact has come from using transfected connex-
in-null cell models expressing one or more exogenous connexins.
While this does provide useful information, observations obtained
using expressed transgenes need to be interpreted in the context of
native tissue systems. This requires taking into account tissue spe-
ciﬁc connexin expression, tissue architecture, molecular composi-
tion of cell–cell interfaces, and regulation via signal transduction
pathways. In this review we summarize the current state of the
art of how connexins interact and discuss implications for this in
regulating tissue function.
2. Molecular basis for connexin compatibility
Connexins are multipass transmembrane proteins with both the
N- and C-termini oriented towards the cytosol (Fig. 1). There are 21
human connexin genes that are translated into functional proteins.
Fig. 1. Structure and interactions between human connexins. (A) Shown is a dendrogram arranged using amino acid homology [5], where human connexin protein names
were used (connexin; Cx) and gene names are in italics. (B) Line diagram of a generic connexin, showing both the N-terminus (NH2) and C-terminus (CT) oriented towards the
cytoplasm. Other protein elements include the two Extracellular Loop (EL) domains, four Transmembrane (TM) domains, and Cytoplasmic Loop (CL) domain. (C) Diagram of
different classes of channels, including homomeric, heterotypic and heteromeric.
Table 1
Motifs which regulate heteromeric compatibility.
R type
Cx43 151 LLRTY 155
Cx46 145 LLRTY 149
Cx50 147 LLRTY 151
Cx45 173 LMKIY 177
Cx47 209 LMRVY 213
Cx36 195 ISRFY 199
Cx31.9 132 ARRCY 136
W type
Cx26 132 LWWTY 136
Cx30 132 LWWTY 136
Cx30.3 127 LWWTY 131
Cx31 127 LWWTY 131
Cx32 131 LWWTY 135
Other
Cx37 151 LMGTY 155
Cx40 149 LLNTY 153
Shown are motifs in the transition between the cytoplasmic loop (CL) and third
transmembrane (TM3) domains that help confer heteromeric speciﬁcity. R type,
and W type designation is from [7,8]. See also Figs. 2 and 3.
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alpha connexins, beta connexins and a third cluster with interme-
diate homology composed of gamma, delta and epsilon connexins
[3–5].
Twelve connexins interact in order to form a complete gap
junction channel; six connexins in the plasma membrane of one
cell oligomerize and dock with compatible hexamers on an adja-
cent cell [2,6]. Hexamers that act as bona ﬁde plasma membrane
channels without docking are called hemichannels. Gap junction
channels composed of a single type of connexin protein are
homomeric; heteromeric channels contain two or more different
types of connexins (Fig. 1). Heterotypic channels are formed by
a hexamer on one cell docked to a hexamer with different conn-
exin composition on the other. Heterotypic channels are most
typically formed from two homomeric hexamers (Fig. 1), however,
they can also consist of a homomeric and heteromeric hexamer or
two heteromeric hexamers. Based largely on sequence homology,
connexin structure determination and the analysis of connexin
interactions in model systems, there is a considerable amount
known about the molecular determinants that regulate connexin
compatibility.
2.1. Heteromeric compatibility
The amino acid homology dendrogram in Fig. 1 provides a rea-
sonable guide to heteromeric compatibility among connexins [5,7].
Heteromeric compatibility of alpha vs. beta connexins correlates
well with a signature amino acid motif localized at the interface re-
gion where the cytosolic intracellular loop (CL) domain transitions
into the third transmembrane domain (TM3) (Table 1; Fig. 2). For
most alpha connexins, this motif contains a conserved arginine
or lysine residue (which we have referred to as R type connexins)
[7]. By contrast, beta connexins contain a di-tryptophan (‘‘WW’’)
motif (W type connexins) [7,8].
Control of hetero-oligomerization by R and W motifs is most
likely indirect. Based on the high resolution structure of Cx26,
the WW motif is localized to the cytosol-membrane interface of
the cytoplasmic leaﬂet and does not directly mediate interprotein
connexin–connexin interactions [7,9]. Instead, several broadlyconserved amino acids in TM2 and TM4 near the extracellular
aspect of these domains form salt bridges or hydrogen bonds to
stabilize hexamers [9]. Moreover, mutations in amino acids di-
rectly involved in connexin–connexin interactions are associated
with human disease [10,11]. Thus, roles for R and W type motifs
in regulating hetero-oligomerization are indirect and most likely
due to control of the initiation of oligomerization as opposed to
hexamer stabilization.
In fact, R type and W type connexins oligomerize via different
pathways, which, in turn, plays a key role in preventing heteromer
formation between them. The most thoroughly studied R type
connexin is Cx43. In contrast to most oligomeric transmembrane
channel proteins, Cx43 is stabilized as monomers in the endoplas-
mic reticulum (ER) and only oligomerizes after transport to the
trans Golgi network (TGN) (Fig. 3) [7,12–14]. Part of this pathway
is regulated by a quality control protein, ERp29, which binds to the
second extracellular loop domain and stabilizes a conformation
Fig. 2. Heteromeric and heterotypic compatibility. (A) Location of heteromeric and heterotypic compatibility motifs. Shown are selected connexins, gene homology group,
heteromeric speciﬁcity motif in the transition between the cytoplasmic loop (CL) and third transmembrane (TM3) domains and heterotypic speciﬁcity motif in the second
extracellular loop (EL2) domain. (B) Heteromeric interactions indicated by the wheel diagram where connexins known to form heteromeric channels are connected by dashed
lines. The solid dividing line separates beta connexins (white) from other connexins to indicate a lack of heteromeric compatibility. (C) Heterotypic interactions indicated by
the wheel diagram where connexins known to form heterotypic channels are connected by dashed lines. There are conﬂicting data regarding heterotypic Cx30 and Cx31
containing channels, this is indicated by the gray dashed lines (see text). The solid dividing lines show three putative heterotypic compatibility groups which do not align with
overall amino acid homology groups. Based on [1,18,20,34,35,38,39,65–67,89,90,92,97,101,106–112,113].
Fig. 3. Connexin oligomerization pathways. Connexins are co-translationally inserted into the ER membrane. Depending on the connexin subtype, oligomerization can occur
either in the ERGIC (W type, Cx32, white) or the TGN (R type, Cx43, shaded). The potential for connexin oligomerization in the ER, driven by high levels of connexin
expression, is also shown for Cx32. Hemichannels are subsequently transported to the plasma membrane, where they can function as channels or pair with hemichannels on
adjacent cells to form complete intercellular channels. Channels at the plasma membrane further assemble into semi-crystalline arrays known as gap junction plaques, which
can contain from tens to thousands of channels. Homogenous plaques are composed of either a single connexin or heteromeric connexins (not shown). Heterogeneous
plaques contain regions enriched for different connexins. Adapted from [2], with permission.
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However, arginine 153 at the CL to TM3 interface is also required
to maintain monomeric Cx43 in the ER (Table 1) [14]. Moreover,
substituting tryptophan for arginine at position 153 destabilizes
Cx43, resulting in premature oligomerization and misfolding. It is
likely that the substitution of a bulky hydrophobic amino acid for
a charged amino acid alters the positioning of TM3 relative to
the plane of the membrane, which is needed to maintain stablemonomers. This change in amino acid may also impair ERp29 bind-
ing, which would further destabilize a monomeric conformation.
Cx46, another R type alpha connexin, has also been shown to oligo-
merize in the TGN [15]. It is likely that other R type connexins fol-
low a comparable TGN oligomerization pathway but this has not
been directly demonstrated. In particular, whether connexins other
than Cx43 interact with ERp29 or a comparable chaperone remains
to be determined.
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are W type beta connexins, oligomerize in the ER [13,14]. Both the
WW motif and the inability to bind to ERp29 promote Cx32 oligo-
merization in the ER. However, at low levels of expression, Cx26
and Cx32 do not oligomerize when transport out of the ER is inhib-
ited with brefeldin A [16]. Clearly, stabilizing monomeric connex-
ins in the ER is a saturable process, since Cx43 overexpression
can force premature oligomerization [17]. Thus, it is important to
consider expression level when interpreting results using transfec-
ted cell systems. A conservative interpretation of the current liter-
ature is that oligomerization of W type connexins occurs at a lower
concentration than R type connexins. This difference in oligomeri-
zation capacity between W type and R type connexins provides a
mechanistic basis for heteromeric compatibility, since pre-formed
hexamers will prevent incorporation of connexins that are more
stably maintained as monomers irrespective of the compartment
where they are assembled (i.e. ER and/or TGN).
2.2. Regulation of hetero-oligomerization
In addition to the R type and W type connexins, several connex-
ins do not conform to either category based on amino acid se-
quence homology and are categorized as ‘‘other’’ (Fig. 2; Table 1)
[7]. Two of these are alpha connexins, Cx37 and Cx40, that are par-
ticularly relevant to cardiovascular physiology. Cx40 has a leucine-
asparagine (LN) motif instead of the leucine-arginine (LR) motif
present in Cx43. Despite this motif difference, Cx40 monomers
are stable in the ER, suggesting that the asparagine residue has suf-
ﬁcient charge at the CL to TM3 interface to behave comparably to
an R type connexin [7]. By contrast, Cx37 completely lacks the LR
motif and instead has a methionine-glycine (MG) motif. This motif
has signiﬁcant consequences for Cx37 oligomerization [7]. In HeLa
cells transfected with Cx37, half of Cx37 oligomerizes in the ER
while the remainder is stabilized as monomers. Moreover, substi-
tuting an MG motif for the LR motif on a Cx43 backbone has a sim-
ilar effect, further implicating the MG motif in destabilizing
connexin monomers in the ER.
It is known that both Cx37 and Cx40 have the ability to hetero-
oligomerize with Cx43 [18,19]. Interestingly, Cx37 and Cx40 differ
in dose response of heteromer formation with Cx43 based on sin-
gle channel conductance measurements using an inducible expres-
sion system [20]. In the case of Cx37, channels with intermediate/
low conductance are more prevalent at high levels of Cx37 expres-
sion than at low levels of Cx37 expression, where there are more
channels with high conductance, more similar to homomeric
Cx37. By contrast, Cx40 at a low level of expression shows more
intermediate conductance channels than at high Cx40 expression.
Since vascular gap junction composition is variable and tends to
show less co-localization of Cx37 with Cx40 and Cx43 in situ, het-
ero-oligomerization between Cx37, Cx40 and Cx43 is highly likely
to be regulated rather than stochastic [21–24]. These data on
monomer stability, along with the differential monomer stability
of Cx37 and Cx40 suggest a potential model for regulated hetero-
oligomerization (Fig. 4). For Cx40 and Cx43, monomer stability is
comparable (Fig. 4A), and so at a matched level of expression, het-
eromeric Cx40 + Cx43 should be the predominant type of channel.
However, when Cx40 expression increases, this may saturate the
capacity of Cx43 to hetero-oligomerize, resulting in more homo-
meric Cx40. Cx37 has the reverse situation (Fig. 4C). In this case,
low levels of Cx37 would be prone to oligomerization in the ER,
preventing hetero-oligomerization with Cx43. Higher levels of
Cx37 are expected to increase the Cx37 monomer pool, which
may increase the potential to hetero-oligomerize with Cx43.
Regulated hetero-oligomerization can also occur when connex-
in monomers are highly stabilized. For example, in some cells co-
expressing Cx43 and Cx46, Cx46 is retained as monomers in theTGN while Cx43 assembles into homomeric channels (Fig. 4B)
[15,25]. Differential hetero-oligomerization occurs in several cell
types, including osteoblasts and lung alveolar epithelial cells
[15,25,26]. Moreover, differential Cx43 + Cx46 hetero-oligomeriza-
tion is dependent on cell phenotype. The best example of this is in
alveolar epithelial cell differentiation, where type II cells restrict
Cx43 + Cx46 hetero-oligomerization until they differentiate into
type I cells, where Cx43 and Cx46 hetero-oligomerize [25,26].
The functional role for this change in oligomerization is not known
at present.
A likely candidate to regulate hetero-oligomerization between
these different alpha connexins is ERp29 [13]. Whether this is
the case will require demonstrating that ERp29 interacts with
other connexins beyond Cx43. However, we propose that ERp29
or other quality control chaperones act as a ‘‘rheostat’’ to alter
connexin assembly. In this model, changes in expression, activity
or target afﬁnity either promote or inhibit oligomerization. Orga-
nelle microenvironment, such as changes in lumen pH, calcium
and/or membrane lipid composition could also inﬂuence connexin
oligomerization. In particular, controlling whether connexins oli-
gomerize in the same or different intracellular compartments pro-
vides a potential mechanism for regulated hetero-oligomerization.
Testing this in native systems or in disease states where quality
control is impaired is anticipated to provide evidence to determine
whether this is the case.
2.3. Heterotypic compatibility
Hemichannel docking is controlled by motifs in the connexin
extracellular loop domains [27]. Based on the high resolution
structure of Cx26 channels there are several key hydrogen bonds
that need to form for proper hemichannel docking to produce a
complete gap junction channel (Fig. 5) [9,28,29]. As is the case with
heteromeric compatibility, there are compatible and incompatible
combinations of heterotypic hexamers. However, heterotypic com-
patibility does not parallel heteromeric compatibility (Fig. 2) [27].
Instead, there are two different prevailing heterotypic compat-
ibility groups, Group 1 and Group 2 that can be categorized by
compatibility motifs in the second extracellular loop (EL2) domain
(Table 2) [28]. By contrast, the signiﬁcant level of amino acid
homology in the ﬁrst extracellular loop domain (EL1) indicates this
domain may be less critical for heterotypic speciﬁcity than the EL2
domain [28].
The consensus EL2 motif for both Group 1 and Group 2 connex-
ins is very similar (Table 2). For Group 1 connexins, the consensus
EL2 sequence is U(K/R)CxxxPCPNxVDCXWS (Table 2). The
signature lysine/arginine (K/R) and asparagine (N) residues are
particularly critical as speciﬁcity determinants for Group 1
heterotypic interactions. The Group 2 consensus sequence,
UxCxxxPCPNxVHCXWS, differs from Group 1 connexins in that
the initial K/R residue is not conserved and has a histidine (H) in-
stead of the asparagine found in the Group 1 connexins. Despite
such close similarity in sequence, functional data demonstrate that
a few key amino acids have a profound effect on heterotypic com-
patibility (below).
Some connexins do not match well with either consensus motif.
Most dramatically, Cx31 has an additional amino acid insertion in
this EL2 motif that is not present in other connexins, which alters
the spacing between the conserved cysteine residues (Table 2). Hu-
man Cx31 is heterotypically compatible with several Group 1 and
Group 2 connexins, despite the observation that mouse Cx31 is not,
suggesting that this difference in EL2 has functional ramiﬁcations
[30,31]. Cx36 and Cx37 also do not conform well with either EL2
consensus sequence since they have neither the H nor N signature
residue. Cx40 has an H residue at position 192, suggesting that it
belongs in Group 2, although it lacks the bulky hydrophobic
Fig. 4. Hypothetical monomer stability model for regulated hetero-oligomerization. Different connexins are depicted by different colored ovals, yellow represents quality
control chaperones which stabilize monomeric connexins (e.g. ERp29 [13]). (A) A cell expressing connexins with matched monomer stability would have oligomerization
occur in the same intracellular compartment and be expected to form fully heteromeric channels. A pair of connexins with matched monomer stability are Cx40 (light) and
Cx43 (dark) [7]. (B) A cell expressing connexins where one connexin has greater monomer stability than another would have restricted hetero-oligomerization, leading to
monomeric channels. A pair of connexins with this type of mismatched monomer stability are Cx46 (light) and Cx43 (dark) [15]. (C) A cell expressing connexins where one
connexin has less monomer stability than another would have reduced hetero-oligomerization as a result of prior hexamer formation. A pair of connexins with this type of
mismatched monomer stability are Cx37 (light) and Cx43 (dark) [7]. In either case B or C, expression and function of the connexin quality control pathway can potentially act
as a ‘‘rheostat’’ to regulate hetero-oligomerization by a direct effect on relative monomer stability.
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motifs.
Given these differences, we propose to refer to heterotypic com-
patibility motifs as either a K-N type motif, an H type motif or
‘‘other’’ (Table 2). Connexin classiﬁcation based on CL-TM3 and
EL2 motifs is shown for selected connexins in Fig. 2. Note that there
are connexins with many different combinations of these motifs.
Interestingly, Cx37 falls into the ‘‘other’’ category for both the CL-
TM3 and EL2 motif, underscoring the unique regulation of this
connexin likely critical for its physiologic function.The high resolution structure of Cx26 has enabled the molecular
basis for heterotypic Cx26:Cx32 interactions to be examined in de-
tail [9,28]. Heterotypic compatibility between Cx26 and Cx32 is
mediated by conserved positively charged residues (K, R and N)
that interact along with a critical aspartate (D) to form hydrogen
bonds to stabilize channel docking (Fig. 5). On the other hand,
the conserved histidine (H) residue in H type connexins does not
form a comparably stable complex with the K-N type EL2 motifs.
This was elegantly shown by demonstrating that mutant forms
of Cx32 (Cx32N175H and Cx32N175D) that were unable to
Fig. 5. Structural homology model of a heterotypic Cx26/Cx32 gap junction channel. One pair of end-to-end docked Cx26 and Cx32 subunits is highlighted as ribbon and line
diagrams overlaid on the structural model. Six hydrogen bonds at the EL2–EL2 docking interface are predicted by the homology model (inset). Residues involved in the spatial
positioning of the interface are labeled and the central carbon atoms of the residues involved in hydrogen bonding are represented by a dark oval. Two hydrogen-bond
clusters are shown: N175 (Cx32) bonding with K168, T177 and D179 (Cx26) and N176 (Cx26) bonding with K167, T176 and D178 (Cx32). Adapted from [28] with permission.
Table 2
Motifs which regulate heterotypic compatibility.
Group 1 – K-N type
Consensus – U(K/R)CxxxPCPNxVDCXWS
Cx26 167 VKCNAWPCPNTVDCFVS 183
Cx30 167 LKCGIDPCPNLVDCFIS 183
Cx32 166 VKCDVYPCPNTVDCFVS 182
Cx46 179 YRCDRWPCPNTVDCFIS 195
Cx50 181 YRCSRWPCPNVVDCFVS 197
Group 1 – Other
Cx31 162 VQCANVAPCPNIVDCYIA 179
Group 2 – H type
Consensus – UxCxxxPCPHxVDCXWS
Cx30.3 162 VACSVEPCPHTVDCYIS 178
Cx31.9 164 FACAGPPCPHTVDCFVS 182
Cx43 185 YTCKRDPCPHQVDCFLS 201
Cx45 207 YVCSRLPCPHKIDCFIS 223
Cx47 240 FPCSRQPCPHVVDCFVS 256
Cx40 183 HVCRRSPCPHPVNCYVS 199
Group 2 – Other
Cx37 185 FVCQRAPCPYLVDCFVS 201
Cx36 229 YECNRYPCIKEVECYVS 245
Shown are motifs in the second extracellular loop (EL2) domain that help confer
heterotypic speciﬁcity. Group 1 and Group 2 designations are from [28]. The con-
sensus amino acid sequences for K-N and H type EL2 domains are also shown,
where / refers to hydrophobic residues, X refers to aromatic residues, and w refers
to amino acids with large aliphatic side chains [105]. Cx31, Cx36 and Cx37 do not ﬁt
well in either the K-N or H type categories. Note that aside from a few key residues
(underlined, bold), the K-N and H type consensus sequences are comparable. See
also Fig. 2.
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compensatory mutations in Cx26 (Cx26K168V and Cx26D179N
respectively) [28]. Critically, the Cx32N175D mutation, which isunable to form gap junction channels, causes Charcot–Marie–Tooth
disease, underscoring the importance of proper hemichannel
docking in this and other connexin-related diseases [32].
In addition to beta connexins, the two alpha connexins, Cx46
and Cx50 are also K-N type connexins. Moreover, a beta connexin,
Cx30.3, is an H type connexin (Fig. 2; Table 2). This raises the po-
tential for a heteromeric hexamer containing both K-N type and
H type connexins (e.g. Cx46 and Cx43) to dock with a hexamer con-
taining either another K-N type connexin. This would require pre-
cise alignment of compatible connexins in hemichannel docking
and so innate incompatibility seems a more likely outcome to
dominate and prevent a heterotypic interaction. However, hetero-
typic compatibility seems to be remarkably ﬂexible, which may
permit unusual docking interactions. For instance, Cx46 has been
demonstrated to be heterotypically compatible with both K-N type
connexins (Cx26, Cx32, Cx50) and an H-type connexin (Cx43) [33].
Cx32N175D also can partially interact with wild type Cx26 [28],
consistent with the concept of plasticity in heterotypic
compatibility.
Also there are conﬂicting data in the literature as to whether
human Cx30 is heterotypically compatible with H type connexins,
e.g. Cx43 and Cx47 (see below) [34,35]. Interestingly, the more var-
iable part of the signature K-N EL2 domain for human Cx30 lacks
the aromatic residue at position 171 that is present in other K-N
type connexins. Instead, Cx30 has an aspartate residue (D), which
is also found in Cx43 at position 190 (Table 2). Thus, differences
in Cx30 underscore the more general concept that heterotypic
compatibility is inﬂuenced by structural elements that are not di-
rectly involved in inter-loop hydrogen bonding. Examining the
compatibility proﬁle of targeted point mutations will help deter-
mine whether this is the case.
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heterotypic channels
3.1. Use of expression systems
One approach to determine whether connexins interact is to use
connexin-null cells that are transfected to heterologously express
one or more connexins. Mammalian connexin-null cell models that
have been used for this purpose include BHK, HeLa, N2A, SK Hep1,
or RIN cells (e.g. [8,16,18,31,36–38]). In addition to connexin null
cells, it can also be useful to transfect connexins into cell lines
expressing a single connexin for the purposes of evaluating het-
ero-oligomerization. These mammalian expression systems are
amenable to biochemical, morphological and functional analysis.
Xenopus oocytes, in which endogenous Cx38 is knocked down
using antisense oligonucleotides, provide a system that is espe-
cially amenable to double, whole-cell, voltage clamp measurement
of gap junction properties, given their size [39,40]. In mammalian
cells it is possible to assess the properties of gap junctions as well
as their comprising channels [41].
The potential for high levels of connexin expression is a partic-
ular concern with the use of heterologous expression systems since
this can yield false positives, e.g. by over-representing events such
as formation of channels that might occur but at extremely low,
sub-physiologic levels. Accumulation of misfolded connexins could
also have an impact on channel function by inducing cell stress re-
sponses. Relative connexin stoichiometry is also difﬁcult to control,
especially when relying strictly on immunoblots, which can pro-
vide quantitative insight on expression levels but not deﬁnitive
composition of assembled channels. Analysis of cells with radiola-
beled connexins coupled with immunoprecipitation and standards
of known speciﬁc activity is one way to more quantitatively deﬁne
heteromer stoichiometry [42–44]. Inducible expression systems
are another approach that enables gap junction channels of differ-
ing stoichiometry to be formed and analyzed in the same cell back-
ground (e.g. [8,20]).
Cells expressing multiple connexins enable heteromeric com-
patibility to be measured whereas two populations of cells
expressing different connexin isoforms can be co-cultured to as-
sess heterotypic compatibility. Each of these systems allows conn-
exin composition to be manipulated and is particularly useful for
analysis of the impact of mutations and chimeras on connexin–
connexin interactions.
The relative simplicity of transfected cell systems is a strength
of the approach, since analysis is performed using a single cell type
expressing one vs. two connexins. This is also a pitfall of the ap-
proach though, because it is difﬁcult to match the stoichiometry
and context of connexin expression in a native tissue using a het-
erologous system.3.2. Morphologic criteria for heteromeric and heterotypic interactions
Immunoﬂuorescence microscopy can provide some clues as to
whether connexins may be compatible, based on whether two
different connexins co-localize or not. Of course, antibody speci-
ﬁcity and lack of cross-reactivity are critical for the success of
any immunodetection technique [23,45]. However, even conven-
tional imaging techniques and confocal microscopy are subject
to the Rayleigh limit of 250–300 nm resolution in the x–y plane,
which is well above the diameter of a gap junction channel
(20 nm) [9]. Thus, immunoﬂuorescence co-localization could re-
ﬂect a mixture of homomeric/homotypic channels within the
same gap junction plaque and not necessarily reﬂect heteromer-
ization (e.g. Fig. 3). On the other hand, if a particular cell–cell
interface is known to be composed of two cells expressingdifferent connexins, then co-localization would support hetero-
typic compatibility.
Getting beyond the resolution limit of ﬂuorescence microscopy
is essential for deﬁnitive morphological analysis of connexin het-
ero-oligomerization. Photoactivatable molecules (FlAsH, ReAsH)
have been used to tag engineered connexins and offer the ability
to translate ﬂuorescence imaging to the EM level of resolution
[46,47]. However this approach is not well suited to the simulta-
neous imaging of two different connexin isoforms in the same
sample.
Fluorescence Resonance Energy Transfer (FRET) microscopy is
another approach that has been used to measure protein–protein
interactions within 10 nm [48,49]. Of relevance to connexins, FRET
microscopy was used to demonstrate that Cx26, Cx30 and Cx31
form heteromeric channels in transfected keratinocytes [50]. It is
surprising that FRET microscopy has not been more widely used
to measure hetero-oligomerization between other connexins in
other cell systems. Also, while useful for transfected model sys-
tems, FRET requires ﬂuorescently tagged proteins and cannot be
used to image heteromers in native tissues.
In the last several years there have been advances in the ﬁeld of
super-resolution ﬂuorescence microscopy, which extends the limit
of resolution to 20–50 nm making the localization of small protein
complexes possible. These include Photoactivation Localization
Microscopy (PALM) [51] and Stochastic Optical Reconstruction
Microscopy (STORM) [52]. STORM relies on photo-switchable
ﬂuorescent antibodies that differ from conventional ﬂuorescent
antibodies in that they are double labeled. Imaging in STORM uses
an activation/deactivation cycle to temporally separate probes that
are otherwise unresolvable. This next generation technology en-
ables studying in situ the ﬁne structure of subcellular components
including the plasma membrane, cytoskeleton, focal adhesions and
tight junctions [53–56]. It is likely to have comparable utility in
studying the ﬁne structure of gap junction plaques as well,
although this level of resolution is still too coarse to deﬁnitively as-
sign two different connexins to the same channel, reﬁnements to
superresolution microscopy may enable detection of heteromeric
channels. Nonetheless, super-resolution microscopy presents a no-
vel way to approach questions related to the trafﬁcking and assem-
bly of connexins into channels, as well as more general application
to characterizing gap junction plaque composition.
The Duolink Proximity Ligation Assay (PLA) is another approach
which can increase the ability to detect protein–protein co-locali-
zation to within 40 nm [57]. The PLA assay is based on using
two different primary antibodies coupled to oligonucleotides that
anneal and can be ligated when in close proximity to form a circu-
lar DNA molecule. This DNA is then ampliﬁed by rolling circle DNA
synthesis and detected using ﬂuorescent oligonucleotides. Thus,
the ﬂuorescence in and of itself is the result of an ampliﬁed signal
that is created at the expense of resolution. However, the inherent
resolution of the PLA technique lies in the proximity of the two
antibodies, which enable the DNA to circularize and anneal; this
essentially provides a yes or no answer as to whether two proteins
are within 40 nm, again larger than the diameter of a gap junction
channel. Nonetheless, this approach was successfully used to char-
acterize complexes of ZO-1 and voltage gated sodium channels
with gap junction plaques [58,59].
Transmission and freeze fracture EM enable high resolution
imaging and, when combined with immunogold labeling, can as-
sign speciﬁc connexins to highly localized areas of gap junction
plaques. Freeze fracture is particularly informative, since the gap
junction particles are readily identiﬁable and can be aligned to
immunogold labeling [60–63]. The utility of the freeze fracture ap-
proach was further extended through the development of matched
double-replica freeze fracture replica immunolabeling (DR-FRIL)
[45]. In this approach, both sides of the fracture plane are retrieved
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followed by secondary antibodies conjugated to differently sized
gold particles [45]. While technically challenging, this approach
enables connexins on both sides of a plaque to be identiﬁed to high
resolution and in a native tissue. For instance, DR-FRIL was used to
demonstrate that in the retina, Cx36 and Cx45 are in close apposi-
tion in the same gap junction plaque [45]. However, heterotypic
Cx36 + Cx45 was not detected, suggesting that they were unlikely
to form heterotypic channels, as was previously thought to be the
case.
3.3. Biochemical criteria
Gap junction hemichannels are relatively stable structures and
can be isolated under deﬁned solubilization conditions. This en-
ables co-immunopuriﬁcation to be used as a criterion for hetero-
oligomerization. This has been used with both native and tagged
connexins to demonstrate a direct interaction [26,36,38,61,64–68].
This approach is best applied to transfected cell models, where
the two connexins to be tested are at comparable and high levels
of expression. Co-immunopuriﬁcation has also been used in native
cell and tissue systems to demonstrate hetero-oligomerization
[26,61,69,70]. One pitfall of co-immunoprecipitation is that while
heteromeric channel formation can be detected, it is difﬁcult to
determine the extent of hetero-oligomerization. In other words,
heteromer detection does not necessarily mean that the majority
of gap junction channels are in fact heteromeric.
Several studies have demonstrated that connexin channels par-
tition into cholesterol enriched membrane microdomains (also
known as lipid rafts) and associate with caveolins, which is impor-
tant for connexin trafﬁcking from the TGN to the plasma mem-
brane [71–74]. Locke et al. [72] extended this analysis to
measure differential partitioning of Cx26 homomers, Cx32 homo-
mers and Cx26 + Cx32 heteromers into detergent resistant mem-
brane microdomains. Critical keys to the success of this approach
were to use multiple different detergents and detergent concentra-
tions coupled with sucrose gradient ﬂotation centrifugation. In TX-
100 and NP-40 solubilized samples, homomeric Cx32 and hetero-
meric Cx26 + Cx32 co-migrated with a lipid marker for microdo-
mains, GM1. By contrast Cx26 was not present in the
microdomain fractions in TX-100 solubilized samples [72]. Thus,
these different classes of hexamers have different biophysical
properties. This has implications for gap junction plaque formation,
since it suggests that different classes of channels will likely self-
partition into distinct regions of a plaque [75].
Measuring the dominant negative effects of connexins on traf-
ﬁcking and delivery is another approach that can be used to iden-
tify potential hetero-oligomerization compatibility in intact cell
models since oligomerization is required for transport to the plas-
ma membrane. This can be done using connexins tagged with dif-
ferent retention and/or localization motifs that, when co-expressed
with untagged connexins inhibit delivery to the plasma membrane
[26,76,77]. Connexins associated with human diseases can also be
analyzed using this approach, either by trapping wild type connex-
ins inside cells or by having retention of the mutant connexin re-
lieved by co-expression with wild type connexins [50,78]. This
approach has particular relevance to human disease by either
impairing gap junction formation or by forming channels with im-
paired function. However, it is important to consider that interac-
tions of mutant connexins with wild type connexins do not
necessarily reﬂect how wild type heteromers form and are instead
relevant to a human disease state. For example, several Cx26
mutations result in an aberrant interaction with Cx43 to cause pal-
moplantar keratoderma associated with hearing impairment that
does not reﬂect the inherent incompatibility of Cx26 and Cx43
[79].3.4. Functional criteria
Formation of functional gap junction channels is the gold stan-
dard for determining whether connexins interact or not. The pre-
dominant methods for measuring intercellular communication
include measuring intercellular transfer of ﬂuorescent dyes of dif-
fering size and charge and electrophysiological approaches, includ-
ing analysis of gap junction conductance, channel gating and single
channel conductance measurements [27,80]. While these ap-
proaches have utility, they do not necessarily correlate well with
the permeability of connexin channels to endogenous substrates,
which is the physiological role for gap junctional communication.
It is feasible, but difﬁcult, to measure transfer of actual, biologically
relevant molecules through gap junction channels, in part because
of the large number of molecules that may be permeants, and the
potentially unknown relevance of these molecules to speciﬁc cell
functions. Metabolic capture of metabolites [81], molecule transfer
through reconstituted channels [82] and indirect assays for metab-
olite transfer [83–85] have all been used to measure intercellular
transfer of cytosolic biomolecules [80]. These methods are best sui-
ted to measure intercellular communication in model cell systems;
a major challenge will be to develop similar approaches that can be
used in intact tissues.
3.5. Heterotypic coupling
Nonetheless, measurements of dye transfer do have some util-
ity in determining whether connexins interact to form functional
channels or not, provided that the size, shape and charge of the
probes used are taken into consideration. Dye transfer also has
been successfully used with intact brain tissue slices and corre-
lated with immunohistological identiﬁcation of connexins and cell
types to measure communication between cells in the central ner-
vous system (e.g. [86–88]). Thus, at face value, it would appear that
heterotypic interactions would be easy to measure using co-cul-
tures of cells expressing different connexins [31].
However, a particularly conspicuous example where measuring
heterotypic coupling has proven problematic involves Cx30. Initial
studies examined N2A and HeLa cells stably transfected with un-
tagged connexin cDNA and then transiently transfected with vec-
tors encoding a marker protein (either EGFP or DsRed). This
method enabled identiﬁcation of live cells expressing different
connexins, effectively labeling transiently transfected cells that
interact with the stably transfected cells expressing a single conn-
exin [89]. In this study Cx30 formed functional heterotypic chan-
nels with Cx32 but not Cx43 or Cx47 as measured by net
junctional conductance. By contrast, a subsequent study using
the same Cx30 cDNA construct engineered into a lentiviral expres-
sion vector and then used to transduce HeLa cells or primary Cx43-
null astrocytes showed heterotypic dye transfer between Cx30 and
Cx32, Cx43 and Cx47 [35]. One possibility is that heterotypic com-
patibility may be context sensitive, e.g. Cx30 expressed by HeLa
cells may be more heterotypically promiscuous than Cx30 ex-
pressed by N2A cells or in a native context of natural oligodendro-
cyte:astrocyte (O:A) junctions [34,35,45]. In particular, connexin
knockout mice were used to show that O:A junctions in Cx32 deﬁ-
cient mice lack Cx30 but retain Cx43 and Cx47 [90] whereas, mice
lacking astrocytic Cx43 show speciﬁc disruption of Cx47 [91].
These data reveal likely heterotypic compatibility in the native tis-
sue and suggest a model where heterotypic docking stabilizes
connexin localization to gap junctions through channel formation.
Tissue speciﬁc connexin targeting and quality control are also
likely to be involved in this process.
Taken together these data are most consistent with the majority
of gap junction channels at O:A junctions being Cx32 + Cx30 and
Cx47 + Cx43 heterotypic channels. Furthermore, in contrast to
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coupling, Cx30 + Cx43 double knockout mice lack detectable O:A
gap junctional communication consistent with two parallel hetero-
typic communication pathways [87,92–95]. As with any mouse
knockout model, connexin deﬁciency can have pleiotropic effects
beyond the effects on speciﬁc, compatible connexins. For instance,
Cx47 deﬁcient mice lacked Cx30 and Cx32 at O:A junctions in addi-
tion to Cx43, due to downstream disruption of MUPP-1 and ZO-1,
which are required junctional components involved in gap junc-
tion plaque organization [87,96].
The physiological roles for heterotypic coupling have not been
fully elucidated. However, several heterotypic channels have
asymmetric voltage gating proﬁles [97]. This means that hetero-
typic channels can be modulated to enable a directional pathway
for intercellular signaling that is not achievable for homomeric or
fully heteromeric channels.
3.6. Heteromeric coupling
Heteromeric coupling is more challenging to measure than het-
erotypic coupling since, by necessity, it involves detecting a change
in the character of intercellular communication rather than the
presence or absence of cell coupling. Differences in permeability
and channel gating have been used as criteria to demonstrate that
functional heteromeric channels have formed [1]. For example,
Cx26 + Cx32 heteromers have enhanced permeability to cGMP vs.
cAMP, whereas Cx32 has comparable permeability to both cyclic
nucleotides, suggesting ﬁne tuning of metabolic signaling can be
mediated by heteromeric channels [70]. Changes in the distribu-
tion of single channel conductances as a result of co-expression
of compatible connexins also provide strong evidence in support
of heteromeric channel formation [20] as well as coupling func-
tional data with biochemical evidence of an interaction between
two connexins [19].
Changes to cardiac conduction examined in the context of conn-
exin knockout and knockin mice demonstrate the complexity of
connexin interactions affecting gap junctional communication in
a physiological context, subject to the caveats mentioned above
(reviewed in [98]). For example, Cx40/ mice show cardiac
arrhythmias and signiﬁcant impairment of AV node conduction
[99,100]. Cx40 + Cx43 heteromers are particularly critical in atrial
conduction, where Cx40 and Cx43 are expressed at comparable
levels as opposed to the ventricle where Cx43 is the predominant
connexin [101]. Spermine sensitivity is a particularly useful diag-
nostic of whether Cx40 is mediating conduction, since Cx40 chan-
nels are sensitive to spermine inhibition, while Cx43 channels are
not [66].
Aside from being a useful tool to dissect out roles for Cx40 in
regulating conduction in the heart, spermine block relates directly
to interactions between Cx40 and Cx43 in heteromeric channels. In
particular, the N-terminal domain of Cx43 is homologous to
spermine; cell permeable peptides corresponding to this Cx43 do-
main speciﬁcally interact with the N-terminus of Cx40 to inhibit
Cx40 channels [18]. This raises the intriguing hypothesis that
Cx40 and Cx43 hetero-oligomerize, but that a large fraction of
these channels may be closed under baseline conditions. However,
the C terminal and cytoplasmic domains of Cx40 and Cx43 also
interact and regulate chemical gating of heteromeric Cx40 + Cx43
channels [102]. Roles for these other domains in regulating how
the N-terminal domain of Cx43 controls Cx40 + Cx43 channels re-
main to be determined. These ﬁndings underscore the need for
additional structural information beyond homomeric Cx26 in order
to understand how hetero-oligomerization affects gap junction
channel function.4. Conclusion and perspectives
Given the high resolution structure of Cx26 and our current
knowledge about motifs that regulate connexin compatibility,
understanding the molecular basis for connexin interactions at
a deeper level seems close at hand. This effort would beneﬁt
from more direct structural data, particularly for other connexins
beyond Cx26. Crystals and high resolution data of heterotypic
connexin channels might be feasible to generate. However, given
the potential for a binomial distribution of combinations of het-
eromeric channels [1], crystalizing and solving structures for
these directly will be exceptionally difﬁcult. Homology modeling
and directed mutations, analogous to the approaches used to
study heterotypic Cx26 + Cx32 interactions is likely to yield use-
ful information on heteromeric compatibility determinants and
permissive combinations of connexin stoichiometry in hetero-
meric channels. In addition to identifying compatibility motifs,
deﬁning structural elements that uniquely regulate heteromeric
and heterotypic channel function have only begun to be ana-
lyzed, particularly when considering how the cytosolic aspects
of different connexins can interact and inﬂuence channel
behavior.
There is also a need to better understand heterotypic interac-
tions, particularly given some of the inconsistencies in the litera-
ture related to heterotypic connexin compatibility. There is a
particular need to transition from transfected cell models to a more
native context to better deﬁne physiologic roles for heterotypic
channels. Cell coupling in the CNS seems to be the most tractable
native context to study heterotypic connexin interactions [94,95].
It would be valuable to expand the scope of these studies to other
tissues, especially the cardiovascular system, but kidney and lung
are other organs that are also likely to have physiologically rele-
vant heterotypic channels [103,104].
Studying heterotypic and heteromeric gap junction channels
in situ presents a particular challenge, especially when trying to
consider native molecules that use these channels for intercellular
communication. Reporter assays seem to be a logical, although
indirect approach. Using a series of well calibrated ﬂuorescent trac-
ers may prove useful to better characterize the charge, shape and
size thresholds for different channels in situ, provided they can
be administered and traced in intact tissues. Advances in whole
animal imaging would be needed to more precisely measure inter-
cellular transfer in situ. However, immunolocalization of connexins
is already starting to beneﬁt from new high resolution techniques
at both the light and EM level and is particularly amenable to anal-
ysis of intact tissues as well. Combining these approaches with
analysis of properly constructed and analyzed transgenic mouse
models should help further our understanding of how multiple
connexins assemble and interact to regulate intercellular commu-
nication in a physiologic context.Acknowledgements
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